Cc1cc(C)nc(SCCn2c(N3CC(C)OC(C)C3)nc3c2c(=O)n(C)c(=O)n3C)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?